Reviva Total Assets from 2010 to 2024

RVPHW Stock

USD 0.21 0.04 23.53%

Reviva Pharmaceuticals Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 18.2 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2018-09-30

Previous Quarter

13.5 M

Current Value

8.1 M

Quarterly Volatility

21.5 M

Covid

Check Reviva Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 10 K, Net Interest Income of 523.9 K or Interest Income of 523.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.36. Reviva financial statements analysis is a perfect complement when working with Reviva Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Reviva Pharmaceuticals Correlation against competitors.

Latest Reviva Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Reviva Pharmaceuticals Holdings over the last few years. Total assets refers to the total amount of Reviva Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Reviva Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Reviva Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reviva Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 23.7 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Reviva Total Assets Regression Statistics

	Arithmetic Mean	6,735,386
	Geometric Mean	50,130
	Coefficient Of Variation	160.40
	Mean Deviation	8,977,048
	Median	2,600
	Standard Deviation	10,803,728
	Sample Variance	116.7T
	Range	31.4M
	R-Value	0.76
	Mean Square Error	52.5T
	R-Squared	0.58
	Significance	0.0009
	Slope	1,843,427
	Total Sum of Squares	1634.1T

Reviva Total Assets History

	2024	18.2 M
	2023	23.7 M
	2022	18.9 M
	2021	31.4 M
	2020	8.8 M

Other Fundumenentals of Reviva Pharmaceuticals

Intangibles To Total Assets

Reviva Pharmaceuticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock
Total Assets		0.95	-0.47	-0.99	-0.72	0.7	-0.47	0.3	0.96	-0.47	1.0	-0.91	0.95	-0.47	0.87
Total Stockholder Equity	0.95		-0.32	-0.98	-0.51	0.51	-0.32	0.05	0.97	-0.32	0.95	-0.89	1.0	-0.32	0.71
Current Deferred Revenue	-0.47	-0.32		0.46	0.86	-0.54	1.0	-0.89	-0.39	1.0	-0.47	0.52	-0.33	1.0	-0.5
Net Debt	-0.99	-0.98	0.46		0.68	-0.67	0.46	-0.23	-0.98	0.46	-0.99	0.94	-0.98	0.46	-0.84
Retained Earnings	-0.72	-0.51	0.86	0.68		-0.87	0.86	-0.85	-0.62	0.86	-0.72	0.74	-0.52	0.86	-0.85
Accounts Payable	0.7	0.51	-0.54	-0.67	-0.87		-0.54	0.58	0.67	-0.54	0.7	-0.77	0.53	-0.54	0.95
Short Term Investments	-0.47	-0.32	1.0	0.46	0.86	-0.54		-0.89	-0.39	1.0	-0.47	0.52	-0.33	1.0	-0.5
Total Liab	0.3	0.05	-0.89	-0.23	-0.85	0.58	-0.89		0.14	-0.89	0.3	-0.28	0.06	-0.89	0.49
Net Invested Capital	0.96	0.97	-0.39	-0.98	-0.62	0.67	-0.39	0.14		-0.39	0.96	-0.97	0.97	-0.39	0.81
Short Long Term Debt	-0.47	-0.32	1.0	0.46	0.86	-0.54	1.0	-0.89	-0.39		-0.47	0.52	-0.33	1.0	-0.5
Total Current Assets	1.0	0.95	-0.47	-0.99	-0.72	0.7	-0.47	0.3	0.96	-0.47		-0.91	0.95	-0.47	0.87
Capital Stock	-0.91	-0.89	0.52	0.94	0.74	-0.77	0.52	-0.28	-0.97	0.52	-0.91		-0.9	0.52	-0.85
Net Working Capital	0.95	1.0	-0.33	-0.98	-0.52	0.53	-0.33	0.06	0.97	-0.33	0.95	-0.9		-0.33	0.73
Short Term Debt	-0.47	-0.32	1.0	0.46	0.86	-0.54	1.0	-0.89	-0.39	1.0	-0.47	0.52	-0.33		-0.5
Common Stock	0.87	0.71	-0.5	-0.84	-0.85	0.95	-0.5	0.49	0.81	-0.5	0.87	-0.85	0.73	-0.5

Click cells to compare fundamentals

About Reviva Pharmaceuticals Financial Statements

Reviva Pharmaceuticals investors use historical fundamental indicators, such as Reviva Pharmaceuticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Reviva Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	23.7 M	18.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Reviva Stock Analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC